切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2024, Vol. 13 ›› Issue (04) : 274 -279. doi: 10.3877/cma.j.issn.2095-3224.2024.04.002

流行与趋势

1990~2021年中国结直肠癌死亡趋势分析
李佳莹1, 王旭丹1, 梁雪1, 张雷1, 李佳英1,()   
  1. 1. 150000 哈尔滨医科大学附属第二医院结直肠肿瘤外科
  • 收稿日期:2024-07-07 出版日期:2024-08-25
  • 通信作者: 李佳英

Analysis of mortality trends of colorectal cancer in China from 1990 to 2021

Jiaying Li1, Xudan Wang1, Xue Liang1, lei Zhang1, Jiaying Li1,()   

  1. 1. Department of Colorectal Tumor Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin 150000, China
  • Received:2024-07-07 Published:2024-08-25
  • Corresponding author: Jiaying Li
引用本文:

李佳莹, 王旭丹, 梁雪, 张雷, 李佳英. 1990~2021年中国结直肠癌死亡趋势分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(04): 274-279.

Jiaying Li, Xudan Wang, Xue Liang, lei Zhang, Jiaying Li. Analysis of mortality trends of colorectal cancer in China from 1990 to 2021[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(04): 274-279.

目的

分析1990~2021年中国结直肠癌死亡率的长期变化趋势,为中国结直肠癌的防控提供科学建议。

方法

从2021年全球疾病负担(GBD2021)数据库获取1990~2021年中国结直肠癌的死亡负担数据,使用年龄-时期-队列模型评估年龄、时期和队列效应。

结果

1990~2021年中国结直肠癌总人群、女性标化死亡率整体呈下降趋势。年龄-时期-队列模型分析显示,1990~2021年中国结直肠癌年龄死亡率随年龄增加呈上升趋势,总人群从0.51/10万增至224.02/10万、男性从0.48/10万增至525.14/10万、女性从0.62/10万增至107.38/10万;时期效应整体呈下降趋势,总人群死亡风险从1992年的1.17降至2021年的0.96、男性死亡风险从1.03降至1.00、女性人群的死亡风险从1.42降至0.89。队列效应均呈下降的趋势。总人群的死亡风险从1897~1904年出生队列组的1.42降至1997~2006年出生队列组的0.48、男性人群的死亡风险从1.03降至0.67、女性人群的死亡风险从2.20降至0.25。在2011~2021年间,死亡风险均呈缓慢上升趋势。

结论

1990~2021年总人群及女性死亡负担下降,男性死亡负担上升,然而,2016~2021年中国不同性别人群的结直肠癌死亡负担均呈缓慢上升趋势,提示死亡负担仍然严峻,应重点加强对中老年男性人群的关注,加强对高危人群进行有效的干预措施,以期减少结直肠癌的死亡负担。

Objective

To analyze the long-term change trend of colorectal mortality in China from 1990 to 2021, and to provide scientific recommendations for the prevention and control of colorectal cancer in China.

Methods

The mortality burden data of colorectal cancer in China from 1990 to 2021 were obtained from GBD2021. The trend of mortality was analyzed by Joinpoint regression model, Using age-period-queue model assessment age, period and cohort effects.

Results

From 1990 to 2021, the overall colorectal population and the standardized mortality rate of females in China showed a downward trend, while that of males showed an upward trend, and the change rates were -11.94%, 2.10% and -29.40%, respectively. APC model analysis showed that from 1990 to 2021, the colorectal age mortality rate in China increased with the increase of age, from 0.51/100 000 to 224.02/100 000 for the total population, from 0.48/100 000 to 525.14/100 000 for males, and from 0.62/100 000 to 107.38/100 000 for females. The period effect showed an overall downward trend, with the risk of death decreasing from 1.17 in 1992 to 0.96 in 2021 in the general population, from 1.03 to 1.00 in men, and from 1.42 to 0.89 in women. All the cohort effects showed a decreasing trend. The risk of death in the general population decreased from 1.42 in the 1897~1904 birth cohort to 0.48 in the 1997~2006 birth cohort, from 1.03 to 0.67 in men, and from 2.20 to 0.25 in women. It is important to note that APC models show a slow upward trend in mortality risk between about 2011 and 2021.

Conclusion

From 1990 to 2021, the total population and the death burden of females decreased, while the death burden of males increased. However, in recent years, the death burden of colorectal cancer in Chinese population of different genders showed a slow upward trend, suggesting that the death burden is still severe. More attention should be paid to middle-aged and elderly males, to reduce the mortality burden of colorectal cancer, effective intervention measures should be strengthened in the high-risk population.

表1 1990和2021年中国结直肠癌死亡人数、死亡率、标化死亡率及变化率情况
图1 中国结直肠癌死亡率的纵向年龄曲线
图2 中国结直肠癌死亡率的时期效应
图3 中国结直肠癌死亡率的队列效应
表2 APC模型中可估计函数的Wald χ2检验
[1]
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2024, 74(3): 229-263.
[2]
Zhou J, Zheng R, Zhang S, et al. Colorectal cancer burden and trends: comparison between China and major burden countries in the world [J]. Chin J Cancer Res, 2021, 33(1): 1-10.
[3]
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2021, 71(3): 209-249.
[4]
Li N, Lu B, Luo C, et al. Incidence, mortality, survival, risk factor and screening of colorectal cancer: a comparison among China, Europe, and northern America [J]. Cancer Lett, 2021, 522: 255-268.
[5]
Goyal V, Dharwal M. SDGs laid down by UN 2030 document[M]. Deep learning technologies for the sustainable development goals: issues and solutions in the post-COVID era. Springer, 2023: 123-132.
[6]
GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021 [J]. Lancet, 2024, 403(10440): 2162-2203.
[7]
GBD 2021 Risk Factors Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021 [J]. Lancet, 2024, 403(10440): 2100-2132.
[8]
GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the global burden of disease study 2016 [J]. Lancet, 2017, 390(10100): 1151-1210.
[9]
Tuo Y, Li Y, Li Y, et al. Global, regional, and national burden of thalassemia, 1990-2021: a systematic analysis for the global burden of disease study 2021 [J]. E Clinical Medicine, 2024, 72: 102619.
[10]
He Q, Mok TN, Sin TH, et al. Global, regional, and national prevalence of gout from 1990 to 2019: age-period-cohort analysis with future burden prediction [J]. JMIR Public Health Surveill, 2023, 9: e45943.
[11]
王朋岗, 刘曦. 中国积极应对人口老龄化: 现实情境与战略方向[J]. 岳麓公共治理, 2023, 2(3): 85-103.
[12]
Zorzi M, Fedeli U, Schievano E, et al. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test [J]. Gut, 2015, 64(5): 784-790.
[13]
Feng RM, Zong YN, Cao SM, et al. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics [J]. Cancer Commun (Lond), 2019, 39(1): 22.
[14]
Li N, Lu B, Luo C, et al. Incidence, mortality, survival, risk factor and screening of colorectal cancer: A comparison among China, Europe, and northern America [J]. Cancer Lett, 2021, 522: 255-268.
[15]
朱陈, 龚巍巍, 钟节鸣, 等. 浙江省重点人群结直肠癌筛查项目设计和实施方案[J]. 中国肿瘤, 2020, 29(12): 899-903.
[16]
Cao M, Li H, Sun D, et al. Classifying risk level of gastric cancer: evaluation of questionnaire-based prediction model[J]. Chin J Cancer Res, 2020, 32(5): 605-613.
[17]
Zhang H, Liu X, Xu C, et al. Guiding tuberculosis control through the healthy China initiative 2019-2030 [J]. China CDC Wkly, 2020, 2(49): 948-950.
[18]
Botteri E, Borroni E, Sloan EK, et al. Smoking and colorectal cancer risk, overall and by molecular subtypes: a meta-analysis [J]. Am J Gastroenterol, 2020, 115(12): 1940-1949.
[19]
Vieira A, Abar L, Chan D, et al. Foods and beverages and colorectal cancer risk: a systematic review and meta-analysis of cohort studies, an update of the evidence of the WCRF-AICR Continuous Update Project [J]. Ann Oncol, 2017, 28(8): 1788-1802.
[20]
Reitsma MB, Fullman N, Ng M, et al. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015 [J]. The Lancet, 2017, 389(10082): 1885-1906.
[21]
Barker-Collo S, Bennett DA, Krishnamurthi RV, et al. Sex differences in stroke incidence, prevalence, mortality and disability-adjusted life years: results from the Global Burden of Disease Study 2013 [J]. Neuroepidemiology, 2015, 45(3): 203-214.
[22]
Lin JH, Giovannucci E. Sex hormones and colorectal cancer: what have we learned so far [J]. J Natl Cancer Inst, 2010, 102(23): 1746-1747.
[23]
Day LW, Velayos F. Colorectal cancer of the elderly [J]. Curr Treat Options Gastroenterol, 2014, 12: 269-282.
[24]
Broeke C, DE Burghgraeve T, Ummels M, et al. Occurrence of malnutrition and associated factors in community-dwelling older adults: those with a recent diagnosis of cancer are at higher risk [J]. J Nutr Health Aging, 2018, 22(2): 191-198.
[25]
Boakye D, Rillmann B, Walter V, et al. Impact of comorbidity and frailty on prognosis in colorectal cancer patients: a systematic review and meta-analysis [J]. Cancer Treat Rev, 2018, 64: 30-39.
[26]
Wang W, Yin P, Liu YN, et al. Mortality and years of life lost of colorectal cancer in China, 2005-2020: findings from the national mortality surveillance system [J]. Chin Med J, 2021, 134(16): 1933-1940.
[27]
Chen B, Jin F. Spatial distribution, regional differences, and dynamic evolution of the medical and health services supply in China [J]. Front Public Health, 2022, 10: 1020402.
[28]
Zorzi M, Fedeli U, Schievano E, et al. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test [J]. Gut, 2015, 64(5): 784-790.
[29]
Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017 [J]. CA Cancer J Clin, 2017, 67(3): 177-193.
[30]
Chinese Society of Cardiology of Chinese Medical Association,Cardiovascular Disease Prevention and Rehabilitation Committee of Chinese Association of Rehabilitation Medicine,Cardiovascular Disease Committee of Chinese Association of Gerontology and Geriatrics, et al. Chinese guideline on the primary prevention of cardiovascular diseases [J]. Cardiology Discovery, 2021, 1(2): 70-104.
[31]
Patel SG, Karlitz JJ, Yen T, et al. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection [J]. Lancet Gastroenterol Hepatol, 2022, 7(3): 262-274.
[32]
Seretis C, Kaisari P, Wanigasooriya K, et al. Malnutrition is associated with adverse postoperative outcome in patients undergoing elective colorectal cancer resections [J]. J buon, 2018, 23(1): 36-41.
[33]
Cohen AK, Syme SL. Education: a missed opportunity for public health intervention[J]. Am J Public Health, 2013, 103(6): 997-1001.
[1] 赵飞鸿, 陈颖杰, 林静芳, 郑晓春, 廖燕凌. 超声引导下周围神经阻滞对髋膝关节置换术后恢复的影响[J/OL]. 中华关节外科杂志(电子版), 2024, 18(04): 457-468.
[2] 罗青杉, 梅海涛, 郝家领, 蔡锦锋, 周润楷, 温玉刚. 连接蛋白43通过调控细胞周期抑制结直肠癌的增殖机制研究[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 344-349.
[3] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[4] 林科灿, 罗柳平. 肝胰十二指肠切除术在胆囊癌和胆管癌应用中的关键问题[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 774-778.
[5] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[6] 梁轩豪, 李小荣, 李亮, 林昌伟. 肠梗阻支架置入术联合新辅助化疗治疗结直肠癌急性肠梗阻的疗效及其预后的Meta 分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 472-482.
[7] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[8] 赵磊, 刘文志, 林峰, 于剑, 孙铭骏, 崔佑刚, 张旭, 衣宇鹏, 于宝胜, 冯宁. 深部热疗在改善结直肠癌术后辅助化疗副反应及生活质量中的作用研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 488-493.
[9] 黄海洋, 邝永龙, 陈嘉胜. 基层医院结直肠肿瘤经自然腔道取标本手术30 例分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 510-518.
[10] 任佳琪, 刁德昌, 何自衍, 张雪阳, 唐新, 李文娟, 李洪明, 卢新泉, 易小江. 网膜融合线导向的脾曲游离技术在左半结肠癌根治术中的应用[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 362-367.
[11] 张迪, 王春霞, 张学东, 李发馨, 庞淅文, 陈一锋, 张维胜, 王涛. 梗阻性左半结直肠癌自膨式金属支架置入后行腹腔镜手术与开腹手术的短期临床疗效比较[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 375-380.
[12] 张蔚林, 王哲学, 白峻阁, 黄忠诚, 肖志刚. 利用TCGA数据库构建基于miRNA的结直肠癌列线图预后模型[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 381-388.
[13] 张伟伟, 陈启, 翁和语, 黄亮. 随机森林模型预测T1 期结直肠癌淋巴结转移的初步研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 389-393.
[14] 季鹏程, 鄂一民, 陆晨, 喻春钊. 循环外泌体相关生物标志物在结直肠癌诊断中的研究进展[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(04): 265-273.
[15] 王小龙, 吴杰, 冯哲, 文浩, 段姝伟, 梁爽, 蔡广研. 心内科病房急性肾损伤且行肾脏替代治疗患者短期预后不良的危险因素分析[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 241-248.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?